Sun Pharma gets exclusive right to commercialise Winlevi acne cream in US, Canada

Sun Pharma, North America CEO Abhay Gandhi said the expiration of the applicable waiting period under the US Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) clears the path for making Winlevi available to patients and healthcare providers in the US and Canada.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3BmfDI0
via IFTTT